» Articles » PMID: 2040045

Use of Endovascular Stents in Congenital Heart Disease

Overview
Journal Circulation
Date 1991 Jun 1
PMID 2040045
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Balloon expandable intravascular stents have been used to support vessel walls in coronary and peripheral arteries in adults. The purpose of this study was to examine the efficacy and safety of these stents in the treatment of congenital heart disease.

Methods And Results: Forty-five stents were placed in 30 patients, who were 0.2-30.2 years old (weight, 3.5-76 kg). Patients with areas of stenosis that were difficult to approach surgically were chosen. Stents were mounted over balloons and placed by standard catheterization techniques. Twenty-three patients had branch pulmonary artery stenosis. Thirty-six stents were placed successfully and had reduced pressure gradients from 50.6 +/- 24 to 15.9 +/- 13.4 mm Hg. Five patients had stents placed after atrial surgery: three in obstructed Fontan repairs, one at the superior vena cava-right atrial junction after sinus venous defect repair, and one at the site of a Glenn shunt. Atrial stents reduced pressure gradients from 9.8 +/- 8.2 to 2.0 +/- 2.6 mm Hg. One patient had a stent placed in the descending aorta after coarctation dilation, and the pressure gradient was reduced from 50 to 25 mm Hg. One patient had pulmonary vein dilation with stent placement. Two stents migrated at the time of placement; one required surgical removal, and one was anchored in place by balloon dilation. One patient died within 24 hours of catheterization because of thrombus obstruction of the Fontan repair. Nine patients have undergone recatheterization. All stented vessels have remained at the same caliber as at original stent placement.

Conclusions: We conclude that balloon expandable stents are useful in selected postoperative stenoses in congenital heart disease.

Citing Articles

Three-dimensional printing-guided percutaneous transcatheter replacement in coarctation of the aorta: a retrospective study.

He Q, Xu C, Liu Y, Jin P, Zhai M, Qiao R Front Cardiovasc Med. 2024; 11:1429470.

PMID: 39735862 PMC: 11672784. DOI: 10.3389/fcvm.2024.1429470.


Safety and efficacy of aortic coarctation stenting in children and adolescents.

Castaldi B, Ciarmoli E, Di Candia A, Sirico D, Tarantini G, Scattolin F Int J Cardiol Congenit Heart Dis. 2024; 8:100389.

PMID: 39712041 PMC: 11658208. DOI: 10.1016/j.ijcchd.2022.100389.


Use of Zephyr stent in congenital heart diseases: A single-center study.

Bandyopadhyay S, Sivaprakasam M Ann Pediatr Cardiol. 2024; 16(4):276-281.

PMID: 38343503 PMC: 10856609. DOI: 10.4103/apc.apc_78_23.


From Crafoord's End-to-End Anastomosis Approach to Percutaneous Interventions: Coarctation of the Aorta Management Strategies and Reinterventions.

Vasile C, Laforest G, Bulescu C, Jalal Z, Thambo J, Iriart X J Clin Med. 2023; 12(23).

PMID: 38068402 PMC: 10707478. DOI: 10.3390/jcm12237350.


Operative experience on descending aorta with Takayasu Arteritis: a review.

Fu Y, Chen Y Front Cardiovasc Med. 2023; 10:1181285.

PMID: 37416916 PMC: 10320220. DOI: 10.3389/fcvm.2023.1181285.